- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨120.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨377.50
7D
-0.3%
1Y
192.3%
Highnoon Laboratories
Market Cap: PK₨48.1b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨908.28
7D
-0.4%
1Y
32.7%
Hoechst Pakistan
Market Cap: PK₨31.0b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,213.00
7D
2.2%
1Y
129.5%
Abbott Laboratories (Pakistan)
Market Cap: PK₨92.0b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨939.65
7D
-1.0%
1Y
36.2%
AGP
Market Cap: PK₨52.7b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨188.09
7D
2.3%
1Y
126.3%